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Mechanisms maintaining mitochondrial integrity range from specific repair pathways to wholesale degrada-
tion of damaged organelles. A recent study in Molecular Cell (Heo et al., 2010) adds another mechanism to
this mitochondrial homeostasis toolkit: mitochondria-associated protein degradation (MAD) that ultimately
directs endoplasmic reticulum-associated protein degradation (ERAD) pathway components to oxidatively
stressed mitochondria.Mitochondria are multifarious cellular
organelles whose disruption can cause
cellular dysfunction, human diseases,
and age-related decline (Shadel, 2008;
Wallace, 2005). Mitochondria house the
ATP-producing oxidative phosphoryla-
tion (OXPHOS) system, which also gener-
ates reactive oxygen species (ROS) as
products of the associated high-energy
electron transfer reactions. ROS are
agents of oxidative stress, and their en-
hanced production/accumulation pro-
motes mitochondrial damage that can
have pathogenic consequences. Thus,
mechanisms to remove damaged mito-
chondrial components, some of which
are encoded by resident mtDNA, are vital
to prevent mitochondrial dysfunction,
including changes in mitochondrial
morphology/dynamics, intrinsic proteo-
lytic pathways, and autophagy/mitoph-
agy (Tatsuta and Langer, 2008) (Table 1).
Though ubiquitin was not present in
the bacterial progenitors of mitochondria,
this posttranslational modification is
increasingly implicated in mitochondrial
events (Livnat-Levanon and Glickman,
2010). However, whether a mitochondria-
associated protein degradation (MAD)
pathway exists that is similar to the ubiq-
uitin-mediated endoplasmic reticulum-
associated protein degradation (ERAD)
pathway has not been clearly established.
In a compelling new study, Heo et al.
(2010) provide evidence from multiple
model systems and approaches that
a conserved mitochondrial protein,
Vms1, interacts with and recruits the
ERAD components Cdc48 and Npl4 to
mitochondria in order to maintain
organelle function. Inability to mount this
mitochondrial stress response leads tomitochondrial respiratory failure and
decreased chronological life span in
yeast, highlighting the importance of the
new MAD pathway.
Heo et al. (2010) show that yeast Vms1
is primarily cytosolic during growth, but
localizes to the mitochondrial outer
membrane in stationary phase or under
oxidative stress conditions. Under these
latter conditions, yeast strains lacking
Vms1 show profound growth defects
and decreased life span due to mitochon-
drial breakdown. Similarly, RNAi of the
C. elegans Vms1 paralog does not cause
growth or developmental defects, but
the animals are sensitive to hydrogen
peroxide and have reduced life span.
Furthermore, peroxide treatment pro-
motes Vms1p mitochondrial localization.
Heo et al. (2010) purified yeast Vms1
and found it binds with Cdc48 and
cofactor Npl4. Importantly, mitochondrial
stress promotes the shuttling of these
ERAD components to mitochondria in
a Vms1-dependent manner.
Interestingly, Heo et al. (2010) also
document that VMS1 null strains are
hypersensitive to the TOR kinase inhibitor
rapamycin, which also causes Vms1p
translocation to mitochondria. At first
glance, this seems to implicate the
conserved TOR signaling pathway in
MAD regulation, but the authors instead
favor the idea that this was a mitochon-
drial oxidative stress response to the
drug. This conclusion was bolstered by
the results of a genetic screen for
suppressors of vms1 rapamycin hyper-
sensitivity, which uncovered three genes
involved in oxidative stress resistance.
This conclusion is apparently at odds
with other reports showing that reducedCell Metabolism 12,TOR signaling extends yeast chronolog-
ical life span (CLS) and reduces cellular
ROS by increasing mitochondrial respira-
tion (Bonawitz et al., 2007; Pan and
Shadel, 2009). It is likely that the timing
and dose of rapamycin treatment are
important determinants of how this drug
affects CLS, which may be the source of
discrepancy between these studies.
With this in mind, it is important to
highlight that TORC1 signaling inhibits
stress-response pathways, including
those tied to oxidative stress and autoph-
agy (De Virgilio and Loewith, 2006). Thus,
TORC1 could prevent MAD from taking
place as a normal part of this regulatory
scheme in addition to simply responding
to rapamycin-induced oxidative stress
as proposed. If so, an important future
goal is to determine if the effect of rapa-
mycin on Vms1 is conserved in mammals
and contributes to the life span-extending
effects of reduced mTOR signaling.
To probe the in vivo relevance of the
newly uncovered MAD pathway, Heo
et al. (2010) examined a known substrate
for ubiquitination and proteasomal decay,
the mitofusin Fzo1 (Cohen et al., 2008).
Absence of Vms1 reduces the rate of
Fzo1 degradation and leads to its accu-
mulation in stationary phase, suggesting
that the Vms1-Cdc48-Npl4 complex
extracts Fzo1 from the outer mitochon-
drial membrane for degradation. A unique
subset of ubiquitin-conjugated proteins
accumulates in vms1 null mutant strains,
pointing to distinct mitochondrial sub-
strates for MAD. Obviously, it will be of
great interest to determine the MAD
substrate profile and which types and
sites of ubiquitination are utilized. Finally,
whether inner membrane proteins, whichDecember 1, 2010 ª2010 Elsevier Inc. 559
Table 1. Mitochondrial Quality Control Pathways
Pathway Purpose
Examples of Specific Pathways or
Proteins Involved
DNA repair Maintain mtDNA stability Base excision repair
Mitochondrial chaperones Facilitate correct import/folding and prevent
protein aggregation
Mitochondrial heat shock family members
(e.g., HSP60)
Autophagy (macroautophagy) Turnover cytoplasmic components, including
mitochondria
Atg proteins (e.g., Beclin-1, LC3)
Mitophagy Specific degradation of damaged mitochondria Atg32
Antioxidant defenses Detoxify mitochondrial ROS Mitochondrial superoxide dismutases
Mitochondrial fusion/fission Interorganelle mixing/segregation
of damaged mitochondria
Opa1/Mfn1,2/Drp1
Mitochondrial proteolysis Turnover of intraorganellar proteins Lon and AAA-proteases
Mitochondrial-associated protein
degradation (MAD)




Previewsin principle stand a greater chance of
being damaged oxidatively by mitochon-
drial ROS, are also substrates for this
pathway should be seriously entertained.
Reports that mitochondrial inner-
membrane proteins are targets for degra-
dation by the cytosolic proteasome are
intriguing in this regard (Azzu and Brand,
2010).
Heo et al. (2010) provide a convincing
case for a MAD mechanism (similar to
ERAD) for specific degradation of oxida-
tively damaged mitochondrial proteins,
adding to the list of important mitochon-
drial quality control (QC) mechanisms
(Table 1). The interdependencies of
repair systems, fission/fusion dynamics,
autophagy/mitophagy, and specific pro-
tein degradation pathways as well as their
redundancy under various stress condi-
tions will be important to determine. For
example, defects in the ubiquitin-protea-
some system (UPS) lead to changes in
mitochondrial dynamics (Livnat-Levanon
and Glickman, 2010), possibly as a way
to segregate damaged mitochondrial
components for removal, and Heo et al.
(2010) show that yeast lacking Vms1 are
more dependent on their intrinsic mito-560 Cell Metabolism 12, December 1, 2010 ªchondrial proteases, Yme1 and Oma1,
and upregulate mitophagy. Once bona
fide substrates of this system are identi-
fied, answers to obvious outstanding
questions can be sought. Are the targets
of MAD nascent misfolded proteins
(like during ERAD), oxidatively damaged
mature proteins, or both? How are poten-
tial substrates inside the organelle recog-
nized and then transported out? Which
additional QC proteins recruit Vms1 to
mitochondria (or vice versa) during times
of stress? Are different stresses read out
differentially? Are ROSor other retrograde
signals involved?
Many components of the yeast and
human mitochondrial proteome are
conserved, and recent estimates suggest
that 20% are involved in inherited
human diseases (Prokisch et al., 2006).
Given the role of mitochondrial dysfunc-
tion and aberrant protein clearing in
neurodegenerative diseases (Tatsuta
and Langer, 2008), components of the
MAD pathway are attractive candidate
disease genes. Clearly, the budding yeast
is still flexing its mitochondrial muscles
as a model system of human biology,
disease, and aging.2010 Elsevier Inc.REFERENCES
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